The Canadian ALS Neuroimaging Consortium (CALSNIC) is a dedicated team working at the forefront of ALS research in Edmonton. Our multidisciplinary group includes neurologists, scientists, and research staff committed to advancing the understanding of amyotrophic lateral sclerosis (ALS) through innovative imaging techniques.
Established to address the urgent need for effective biomarkers in ALS, CALSNIC collaborates across several academic centres. Our mission is to facilitate standardized research that impacts clinical practice, enhances patient care, and leads to breakthroughs in treatment options. With funding from esteemed organizations, we strive to support ALS patients and their families.
Established to address the urgent need for effective biomarkers in ALS, CALSNIC collaborates across several academic centres. Our mission is to facilitate standardized research that impacts clinical practice, enhances patient care, and leads to breakthroughs in treatment options. With funding from esteemed organizations, we strive to support ALS patients and their families.
